Magnus Grenegård

1.5k citations
55 papers · 1.2k indexed · h-index 19
Topics
Platelet Disorders and Treatments (15 papers)Nitric Oxide and Endothelin Effects (8 papers)Antiplatelet Therapy and Cardiovascular Diseases (8 papers)

In The Last Decade

Magnus Grenegård

52 papers receiving 1.1k citations

Peers

Magnus Grenegård
Comparison fields: 5 of 106
  • Molecular Biology 290
  • Immunology 275
  • Hematology 212
  • Physiology 187
  • Surgery 138
Replace Shan‐Chi Liu with:
Shan‐Chi Liu Taiwan
Jingyan Han United States
Jaroslav G. Vostal United States
Qiang Guo China
Lina Hu China
Monika Biniecka Ireland
Seiichi Kobayashi Japan
Wei Tang China
Pei‐Ling Chi Taiwan
Qingtong Wang China
Magnus Grenegård relative to Shan‐Chi Liu Taiwan Shan‐Chi Liu's profile →
Citations per field
00.5×2.7×
Shan‐Chi Liu · 1×
Citations per year

Countries citing papers authored by Magnus Grenegård

Since Specialization
Citations

This map shows the geographic impact of Magnus Grenegård's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magnus Grenegård with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magnus Grenegård more than expected).

Fields of papers citing papers by Magnus Grenegård

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magnus Grenegård. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magnus Grenegård. The network helps show where Magnus Grenegård may publish in the future.

Co-authorship network of co-authors of Magnus Grenegård

This figure shows the co-authorship network connecting the top 25 collaborators of Magnus Grenegård. A scholar is included among the top collaborators of Magnus Grenegård based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magnus Grenegård. Magnus Grenegård is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 9
2 6
3 0
4 21
5 1
6 12
7 16
8 16
9 5
10 45
11 15
12 32
13 18
14 22
15 40
16 9
17 24
18 21
19 11
20 10

About Magnus Grenegård

Magnus Grenegård is a scholar working on Hematology, Immunology and Allergy and Physiology, having authored 55 papers that have together received 1.2k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (15 papers), Nitric Oxide and Endothelin Effects (8 papers) and Antiplatelet Therapy and Cardiovascular Diseases (8 papers). The work is most often cited by research in Hematology (212 citations), Immunology (275 citations) and Immunology and Allergy (76 citations). Magnus Grenegård has collaborated with scholars based in Sweden, United States and Germany. Frequent co-authors include Knut Fälker, Liza U. Ljungberg, T. Bengtsson, Torbjörn Bengtsson, Madelene Lindkvist, Mulugeta M. Zegeye, Geena Varghese Paramel, Ashok Kumar Kumawat, Allan Sirsjö and Stefan Zalavary. Their work appears in journals such as Journal of Biological Chemistry, Blood and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026